Diabetes Mellitus Clinical Trial
Official title:
Population-based Epidemiologic Study of Childhood Diabetes in Chicago: a) Disease Surveillance; b) Family Studies; c) Questionnaire Followup.
The goal of this study is to investigate the epidemiology and natural history of childhood-onset diabetes, whether of autoimmune, non-autoimmune, or mixed etiology in affected probands and their relatives.
The goal of this study is to investigate the epidemiology and natural history of
childhood-onset diabetes, whether of autoimmune, non-autoimmune, or mixed etiology in
affected probands and their relatives. The following hypotheses frame the research questions
to be addressed:
Hypothesis 1. Diabetes as it occurs in youth derives from a spectrum of etiologic processes,
from the insulinopenia of autoimmune type 1 to obesity-related, insulin-resistant type 2
diabetes. A subset of children develop diabetes through a combination of the 2 major
etiologic pathways, with autoimmune ß-cell destruction aggravated by the presence of insulin
resistance related to genetic susceptibility, obesity and/or physical inactivity. A fraction
of young patients are unclassifiable at onset due to severe symptomatology and ambiguities
in measures of ß-cell function. This poses the research challenge of misclassification of
disease, as well as the clinical difficulty of potentially inappropriate treatment … Since
patients are drawn from the city-wide registry, clustering of genetic and behavioral risk
factors will be systematically identified without the selection bias inherent in case series
and clinic-based studies.
Research questions:
1. Is it feasible to distinguish type 1 from early-onset type 2 diabetes at diagnosis?
Which demographic, clinical, and family characteristics are most useful?
2. Is the risk of developing diabetes among siblings of early-onset type 2 or mixed cases
equivalent to that for siblings of type 1 patients? Which characteristics are most
predictive of risk? Hypothesis 2. Changes in the epidemiologic parameters of childhood
diabetes over the past 2 decades are directly related to changes in the prevalence of
risk factors for both type 1 and type 2 diabetes, including obesity, physical
inactivity, and perinatal exposures.
Research questions:
1. Is change in the incidence of childhood diabetes occurring uniformly across all age-,
sex- and ethnic strata?
2. Are secular changes in type 2 incidence rates continuing, and is this occurring in all
age-, sex- and ethnic strata? Hypothesis 3. A complex interplay of heritable,
behavioral, and treatment factors can accelerate or delay the development of chronic
diabetes complications. It is particularly compelling to understand this process in
young patients, those with the most years of productive life at risk. … Recent
observations indicate that features of the metabolic syndrome, over and above glycemic
control, are potent risk factors for macrovascular complications. Familial aggregation
of these traits may itself play a role in determining the risk of chronic complications
among young people with diabetes.
Research questions:
1. Do young people with diabetes who demonstrate signs and symptoms of early complications
have greater insulin resistance or other characteristics that distinguish them from
those patients who are free of complications, controlled for disease duration and
metabolic control?
2. Do young patients with early signs/symptoms of complications have more parents who
themselves have elevated cardiovascular disease risk factors, than patients who are
free of chronic complications, controlled for disease duration and metabolic control?
;
Observational Model: Case-Only
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
| Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
| Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
| Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
| Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
| Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
| Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
| Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
| Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
| Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
| Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
| Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
| Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
| Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
| Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
| Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |